235 filings
Page 5 of 12
424B5
9n6gh94
16 Feb 21
Prospectus supplement for primary offering
7:10am
6-K
01jwt
26 Jan 21
Galmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchol's Novel Anti-Fibrotic Mechanism of Action
11:01am
6-K
ujopa34493svwww5l
17 Dec 20
Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021
7:06am
6-K
1aztl
12 Nov 20
Galmed Pharmaceuticals Reports Third Quarter 2020 Financial Results
7:00am
6-K
maxzkk 04e1
9 Nov 20
Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol
8:30am
6-K
lfqnn1zs
9 Sep 20
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of
10:03am
6-K
7biwbo
14 Aug 20
Current report (foreign)
4:32pm
6-K
st8fpi
6 Aug 20
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
7:13am
6-K
i1aqsuwyrx4knr 6br
8 Jul 20
Current report (foreign)
4:47pm
6-K
zhyae48y3n 7cakrpt
19 Jun 20
Current report (foreign)
4:15pm
6-K
j1uv53i0s5
21 May 20
Current report (foreign)
4:31pm
6-K
3hu pvgeon
18 May 20
Current report (foreign)
4:31pm
6-K
ldle0hdb g46wl
15 May 20
Current report (foreign)
4:50pm
424B5
p9j81dd739o
15 May 20
Prospectus supplement for primary offering
4:41pm
6-K
kyec5ot
14 May 20
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results
7:00am
6-K
qk45vmz
12 Mar 20
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2019 Financial Results
7:19am
6-K
f7sgn2b
6 Nov 19
Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results
7:10am
6-K
25k1he
31 Oct 19
Galmed Pharmaceuticals to Present New Data on Aramchol effect on glucose metabolism, MoA and clinical results at AASLD 2019
9:03am
6-K
6a1ghfk8hc9un
26 Sep 19
Current report (foreign)
8:11am